News

Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer ...
Kytopen Announces Launch of Technology Access Program Supported by an Expanded Applications Team
Company Adds Proven Product Development and Commercial Leader as it Accelerates Launch of Flowfect®...
CAMBRIDGE, Mass. — July 11, 2023 — Kytopen, a leading biotechnology company specializing in...
On International Women in Engineering Day, we pay tribute to the exceptional women who have...
Today, we celebrate Kytopen's sixth anniversary, a journey filled with groundbreaking achievements...
Read the original release at BioCentriq.com NEWARK, NJ, June 6, 2023 – BioCentriq®, a strategic...
Kytopen Reveals Automated High-Throughput Gene Editing Platform to Accelerate Cell Therapy...
Watch this TEDx-style presentation on demand featuring Kytopen Co-Founder and Scientific Advisory...